Mass Cytometry: a robust platform for the comprehensive immunomonitoring of CAR-T-cell therapies. Corneau A, Parizot C, Cherai M, Todesco E, et al. Br J Haematol 2021;194:788-792.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Corneau A, Parizot C, Cherai M, Todesco E, et al. Mass Cytometry: a robust platform for the comprehensive immunomonitoring of CAR-T-cell therapies. Br J Haematol 2021;194:788-792.
PMID: 34041740